Albemarle price target lowered to $75 from $85 at Scotiabank
Scotiabank lowered the firm’s price target on Albemarle (ALB) to $75 from $85 and keeps a Sector Perform rating on the shares. The mid-term ...
Albemarle price target lowered to $68 from $73 at Morgan Stanley
Morgan Stanley analyst Vincent Andrews lowered the firm’s price target on Albemarle (ALB) to $68 from $73 and keeps an Underweight rating on ...
Scotiabank lifts Adeptus Biotech price target to $12, keeps rating
Scotiabank (TSX:BNS) analyst Sung Ji Nam increased the price target for Adeptus Biotechnologies Corp. (NASDAQ:ADPT) to $12.00, up from the previous $10.00, while maintaining a Sector Outperform rating ...
Aurora Cannabis Inc. (TSE:ACB) Given Average Recommendation of “Moderate Buy” by Analysts
Aurora Cannabis Inc. (TSE:ACB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat.com reports. Three ...
Investors rush to protect against Wall Street ‘volatility spikes’
US stocks have risen this year, but traders are hedging against big swings induced by Trump’s erratic policymaking ...
Roth/MKM cuts Canopy Growth stock price target to C$10
Roth/MKM maintained a positive stance on Canopy Growth (NASDAQ:CGC) shares, despite reducing the price target to C$10 from the previous C$15. The firm continues to endorse a Buy rating for the ...